These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 12474049

  • 1. Expression of progastrin-releasing peptide and gastrin-releasing peptide receptor mRNA transcripts in tumor cells of patients with small cell lung cancer.
    Uchida K, Kojima A, Morokawa N, Tanabe O, Anzai C, Kawakami M, Eto Y, Yoshimura K.
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):633-40. PubMed ID: 12474049
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomas.
    Stieber P, Dienemann H, Schalhorn A, Schmitt UM, Reinmiedl J, Hofmann K, Yamaguchi K.
    Anticancer Res; 1999 Dec; 19(4A):2673-8. PubMed ID: 10470218
    [Abstract] [Full Text] [Related]

  • 7. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
    Cohen AJ, Bunn PA, Franklin W, Magill-Solc C, Hartmann C, Helfrich B, Gilman L, Folkvord J, Helm K, Miller YE.
    Cancer Res; 1996 Feb 15; 56(4):831-9. PubMed ID: 8631021
    [Abstract] [Full Text] [Related]

  • 8. Detection of tumor specific gene expression in bone marrow and peripheral blood from patients with small cell lung carcinoma.
    Shingyoji M, Takiguchi Y, Watanabe R, Hiroshima K, Motoori K, Kurosu K, Kasahara Y, Tanabe N, Tatsumi K, Kuriyama T.
    Cancer; 2003 Feb 15; 97(4):1057-62. PubMed ID: 12569606
    [Abstract] [Full Text] [Related]

  • 9. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer.
    Schneider J, Philipp M, Salewski L, Velcovsky HG.
    Clin Lab; 2003 Feb 15; 49(1-2):35-42. PubMed ID: 12593474
    [Abstract] [Full Text] [Related]

  • 10. Pro-gastrin-releasing peptide (Pro-GRP), a tumor marker for small cell lung cancer.
    Oremek GM, Sapoutzis N.
    Anticancer Res; 2003 Feb 15; 23(2A):895-8. PubMed ID: 12820319
    [Abstract] [Full Text] [Related]

  • 11. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.
    Schneider J, Philipp M, Velcovsky HG, Morr H, Katz N.
    Anticancer Res; 2003 Feb 15; 23(2A):885-93. PubMed ID: 12820318
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Interleukin-8/CXCL8 is a growth factor for human lung cancer cells.
    Zhu YM, Webster SJ, Flower D, Woll PJ.
    Br J Cancer; 2004 Nov 29; 91(11):1970-6. PubMed ID: 15545974
    [Abstract] [Full Text] [Related]

  • 20. Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer.
    Molina R, Auge JM, Filella X, Viñolas N, Alicarte J, Domingo JM, Ballesta AM.
    Anticancer Res; 2005 Nov 29; 25(3A):1773-8. PubMed ID: 16033098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.